Furthermore, several studies have demonstrated the proliferative potential of MIR125B1in breast cancer via its targeting of the tumor suppressor p53 gene, which upregulates proliferative tumor pathways like PI3K (Phosphatidylinositol 3-kinase) pathways. The gene discussed is TP53; the disease is breast cancer.